- ... related-topic >Stem Cells</related-topic><see-reference >Blood Donation</see-reference><see-reference >Transfusion</see-reference><site ><information-category >Encyclopedia</information-category>< ...
- ... virus, and human immunodeficiency virus Type 1 in blood donors. Transfusion. 2013 Oct;53(10 Pt ... infections: the time is now! Curr HIV/AIDS Rep. 2012 Sep;9(3):251–8. doi: ...
- ... ovidsp .ovid.com/ovidweb .cgi?T=JS&PAGE =reference&D ... transfusion during pregnancy, birth, and the postnatal period. Obstet ...
- ... therapy had lower total disease sequelae and fewer blood transfusions. Most high-risk patients (kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon) are treated with sirolimus to achieve serum blood levels of 8 to 15 ng/mL.[ 29 , ...
- ... King AA, Noetzel M, White DA, et al. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts. Pediatr Blood Cancer. 2008 Mar;50(3):599–602. PMID: ...
- ... iron as maintenance therapy in anaemic ckd patients. Blood Transfusion. 2019;17((Dimkovic N.) Clinical Department for Renal ...
- ... can be acquired (e.g., maternal-fetal transmission, blood transfusions, inadvertent needle sticks, sharing needles or injection equipment ...
- ... seronegative hospital patients. All of the patients received blood transfusions for a variety of reasons, but half were transfused with seropositive blood while the "matched controls" received seronegative blood. The ...
- ... the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: ...
- ... the uptake of technologies to minimize perioperative allogeneic blood transfusion: An interview study of national and institutional stakeholders. ...
17 results